U.S. markets closed
  • S&P Futures

    3,634.50
    +7.25 (+0.20%)
     
  • Dow Futures

    29,877.00
    +49.00 (+0.16%)
     
  • Nasdaq Futures

    12,201.25
    +49.00 (+0.40%)
     
  • Russell 2000 Futures

    1,851.10
    +6.50 (+0.35%)
     
  • Crude Oil

    45.96
    +0.25 (+0.55%)
     
  • Gold

    1,808.80
    +3.30 (+0.18%)
     
  • Silver

    23.43
    +0.07 (+0.31%)
     
  • EUR/USD

    1.1930
    +0.0011 (+0.10%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.25
    -0.39 (-1.80%)
     
  • GBP/USD

    1.3392
    +0.0009 (+0.07%)
     
  • USD/JPY

    104.2820
    -0.1580 (-0.15%)
     
  • BTC-USD

    18,206.44
    -636.70 (-3.38%)
     
  • CMC Crypto 200

    355.22
    -15.29 (-4.13%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,470.28
    +173.42 (+0.66%)
     

Eiger BioPharma: 3Q Earnings Snapshot

·1 min read

PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $15.7 million in its third quarter.

The Palo Alto, California-based company said it had a loss of 52 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

Eiger BioPharma shares have decreased 39% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.04, a decline of 20% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR